Series A startup

Who invested in BioShin

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2020, from 1 source

Latest round
Series A, $60MSept 2020
Investors
2
See who backed them

The rounds

  1. Sept 2020
    Series A$60M

    Source recorded

Everyone who backed them

OrbiMedPrivate equity1round
Cormorant Asset ManagementPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about BioShin

Who invested in BioShin?

BioShin's investors include OrbiMed and Cormorant Asset Management.

How much has BioShin raised?

BioShin has raised $60M across 1 round since 2020.

When did BioShin last raise?

BioShin's most recent round was a Series A of $60M in Sept 2020.

What was BioShin's biggest round?

Its most recent round, $60M in Sept 2020, is also its largest on record.

Who backed BioShin first?

BioShin's first round on record, in Sept 2020, was backed by OrbiMed and Cormorant Asset Management.

What stage is BioShin at?

BioShin's latest named round is a Series A, in Sept 2020.

Companies like BioShin

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.